ZOTA Stock Overview
Develops, manufactures, and markets pharmaceutical products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Zota Health Care Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹879.95 |
| 52 Week High | ₹1,078.00 |
| 52 Week Low | ₹440.10 |
| Beta | 0.63 |
| 1 Month Change | -13.17% |
| 3 Month Change | 58.49% |
| 1 Year Change | 84.63% |
| 3 Year Change | 146.35% |
| 5 Year Change | 386.29% |
| Change since IPO | 737.76% |
Recent News & Updates
Investors Appear Satisfied With Zota Health Care Limited's (NSE:ZOTA) Prospects As Shares Rocket 33%
Jan 18
Getting In Cheap On Zota Health Care Limited (NSE:ZOTA) Might Be Difficult
Dec 04Zota Health Care (NSE:ZOTA) Will Pay A Dividend Of ₹1.00
Sep 12Recent updates
Investors Appear Satisfied With Zota Health Care Limited's (NSE:ZOTA) Prospects As Shares Rocket 33%
Jan 18Getting In Cheap On Zota Health Care Limited (NSE:ZOTA) Might Be Difficult
Dec 04Zota Health Care (NSE:ZOTA) Will Pay A Dividend Of ₹1.00
Sep 12Is Zota Health Care (NSE:ZOTA) A Risky Investment?
Aug 02Zota Health Care Limited's (NSE:ZOTA) 29% Jump Shows Its Popularity With Investors
Jun 15Zota Health Care (NSE:ZOTA) Has Re-Affirmed Its Dividend Of ₹1.00
Sep 20Zota Health Care (NSE:ZOTA) Has Announced A Dividend Of ₹1.00
Sep 04Are Dividend Investors Getting More Than They Bargained For With Zota Health Care Limited's (NSE:ZOTA) Dividend?
Mar 25What Type Of Returns Would Zota Health Care's(NSE:ZOTA) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Jan 19
Zota Health Care Limited's (NSE:ZOTA) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Dec 15Shareholder Returns
| ZOTA | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -10.4% | -7.5% | -5.6% |
| 1Y | 84.6% | 9.0% | -0.9% |
Return vs Industry: ZOTA exceeded the Indian Pharmaceuticals industry which returned 9% over the past year.
Return vs Market: ZOTA exceeded the Indian Market which returned -0.9% over the past year.
Price Volatility
| ZOTA volatility | |
|---|---|
| ZOTA Average Weekly Movement | 8.5% |
| Pharmaceuticals Industry Average Movement | 6.4% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.4% |
Stable Share Price: ZOTA's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: ZOTA's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 445 | Sujit Paul | www.zotahealthcare.com |
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, wellness, over-the-counter products, ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, heart disease, and thyroid disorders.
Zota Health Care Limited Fundamentals Summary
| ZOTA fundamental statistics | |
|---|---|
| Market cap | ₹22.14b |
| Earnings (TTM) | -₹504.26m |
| Revenue (TTM) | ₹2.46b |
9.0x
P/S Ratio-43.9x
P/E RatioIs ZOTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZOTA income statement (TTM) | |
|---|---|
| Revenue | ₹2.46b |
| Cost of Revenue | ₹1.13b |
| Gross Profit | ₹1.33b |
| Other Expenses | ₹1.83b |
| Earnings | -₹504.26m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -20.04 |
| Gross Margin | 54.14% |
| Net Profit Margin | -20.52% |
| Debt/Equity Ratio | 1.3% |
How did ZOTA perform over the long term?
See historical performance and comparisonDividends
0.1%
Current Dividend Yield-18%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/16 05:44 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Zota Health Care Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.